papillomavirus binding factor (499-510)

Papillomavirus binding factor (499-510) is a synthetic peptide fragment corresponding to amino acids 499 through 510 of the papillomavirus binding factor (PBF) protein, a cellular transcription factor implicated in the regulation of viral and host gene expression. As a defined peptide sequence, it serves as a valuable molecular tool for investigating protein-protein interactions, post-translational modifications, and the functional domains of PBF relevant to papillomavirus biology. The sequence is particularly significant in the context of viral pathogenesis, cellular signaling, and transcriptional regulation, making it a pertinent reagent for researchers studying virus-host interactions and the molecular mechanisms underlying papillomavirus infection.

Protein-Protein Interaction Studies: Researchers utilize this peptide fragment to map and characterize the specific regions of PBF involved in binding to papillomavirus proteins or cellular partners. By serving as a competitive inhibitor or probe in binding assays, it enables the dissection of interaction interfaces and the identification of critical residues mediating association. Such studies are essential for understanding how papillomaviruses hijack host transcription factors to facilitate viral replication and persistence.

Epitope Mapping and Antibody Validation: The defined sequence of papillomavirus binding factor (499-510) is frequently employed as an epitope for generating and validating antibodies against PBF. Synthetic peptides corresponding to unique protein regions allow for the production of highly specific polyclonal or monoclonal antibodies, which are subsequently used in immunoblotting, immunoprecipitation, or immunohistochemical applications. This approach aids in the precise detection and localization of PBF in various biological samples, advancing research into its expression patterns and functional roles.

Phosphorylation and Post-Translational Modification Analysis: The peptide serves as a substrate in in vitro kinase assays or other enzymatic modification studies, facilitating the investigation of potential phosphorylation sites or other post-translational modifications within the PBF protein. By providing a focused target for modifying enzymes, it allows researchers to elucidate regulatory mechanisms that control PBF activity and, by extension, its influence on papillomavirus gene expression.

Peptide-Based Inhibitor Design: The sequence information and structural features of this peptide fragment inform the rational design of inhibitors that can disrupt PBF-mediated interactions. Structure-activity relationship studies using the peptide as a template help identify minimal binding motifs and critical residues necessary for function. Such insights underpin the development of novel molecular tools or research probes to modulate PBF activity in experimental systems.

Structural and Biophysical Characterization: The well-defined nature of the papillomavirus binding factor (499-510) peptide makes it suitable for structural studies using techniques such as nuclear magnetic resonance (NMR) spectroscopy or circular dichroism (CD) analysis. These investigations provide detailed information about the secondary structure, conformational dynamics, and potential interaction surfaces of the peptide, contributing to a deeper understanding of its role within the larger PBF protein and its relevance to papillomavirus-host interactions.

1. Effect of Short-Term Desiccation, Recovery Time, and CAPA-PVK Neuropeptide on the Immune System of the Burying Beetle Nicrophorus vespilloides

2. Zeta-potential-changing nanoparticles conjugated with cell-penetrating peptides for enhanced transfection efficiency

3. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy

4. Immune responses to peptides containing homocitrulline or citrulline in the DR4-transgenic mouse model of rheumatoid arthritis

5. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum